[The experimental research on the perforin and granzyme B expressions to the early diagnostic value of acute rejection response after pancreatic transplantation].
OBJECTIVE
To study the early diagnosis value of acute rejection response to perforin and granzyme B protein expressions around transplantation pancreas tissue after pancreatic transplantation.


METHODS
Twenty-four hybrid landraces were randomly divided into three groups [control group ( I group), transplantation group ( II group), transplantation + immunosuppressive group (III group)]. The transplantation group was treated by pancreatoduodenal allotransplantation, and simultaneously the group of transplantation + immunosuppressants was intervened by cyclosporin A (CsA), mycophenolate mofetil (MMF) and metrisone. The peripheral venous blood was sampled via subclavian vein one day before operation and on the 1st, 3rd, 5th or 7th day after operation respectively, and then the glucose, insulin and glucagons in serum were measured. The grafted pancreatic tissues were collected for pathologic and immunohistochemical examinations at 1st, 3rd, 5th and 7th day after operation.


RESULTS
(1) The levels of blood sugar, insulin and glucagons had no significant difference among groups of control, transplantation and transplantation + immunosuppressant group (P>0.05). (2) By comparing with two experimented groups, the expressions of perforin and granzyme B protein in transplantation pancreas tissue had a significant difference between transplantation group and transplantation + immunosuppressive group (P < 0.05). (3) The time of perforin and granzyme B protein expressions in transplantation pancreas tissue after transplantation was 2-4 days earlier than that of pathological changes in acute rejection.


CONCLUSIONS
The expression alterations of perforin and granzyme B protein are earlier appearance than the pathological changes of acute rejection response in transplantation pancreas tissue, and by combining with routine pathological examination, the acute rejection response can be diagnosed on early stage.
Hu
Wei-ming
WM
Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhang
Zhao-da
ZD
Han
Fang-hai
FH
Zhou
Xiang
X
Meng
Ling-xiang
LX
Ke
Neng-wen
NW
D000818:Animals; D042241:Early Diagnosis; D005260:Female; D005786:Gene Expression Regulation; D006084:Graft Rejection / Q000175:diagnosis* / Q000378:metabolism* / Q000473:pathology; D053804:Granzymes / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D010179:Pancreas / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D016035:Pancreas Transplantation / Q000276:immunology*; D054353:Perforin / Q000378:metabolism*; D013194:Staining and Labeling; D013552:Swine
D054353:Perforin; D053804:Granzymes